Ask Dr P Vijayanand Reddy for Second Opinion

Private, Secure and 100% Trusted

Atleast characters required
Medical reports
invalid valid
I have read and agree to the Terms & Conditions and Privacy Policy
loading
Saving...
Saved

Ask Dr P Vijayanand Reddy for Second Opinion

doctor-image

Dr P Vijayanand Reddy

( MBBS, MD, DNB, ESMO )

Radiation Oncologist

  • MBBS from Osmania Medical College in 1982
  • MD (RT) from Osmania Medical College in 1992
  • DNB (Oncology) in 1993
  • ESMO Medical Oncology Board in 2005
  • “INTERNATIONAL CANCER RESEARCH TECHNOLOGY TRANSFER AWARD” by UICC, Geneva, Switzerland in 1992
  • “NARGIS DUTT MEMORIAL FOUNDATION AWARD” by Nargis Dutt Memorial Foundation, Flushing, New York in 1995
  • “BEST SCIENTIFIC PAPER AWARD” at XVIII National Conference of Assoc. Oncologists of India, Aurangabad in 1996
  • “YOUNG SCIENTIST AWARD” by Indo-American Cancer Congress, New York in 1996
  • “INTERNATIONAL CANCER RESEARCH TECHNOLOGY TRANSFER AWARD” by UICC, Geneva, Switzerland in 1998
  • YOUNG INVESTIGATORS AWARD ‘ by Eli Lilly & Company, USA at New Delhi in 2001
  • “BEST POSTER” AWARD 2008 by American Academy of Ophthalmology at Atlanta, GA, USA
  • “Best Scientific Poster Award 2009” for Histopathology of Retinoblastoma after primary Chemotherapy by ARICON
  • “Best Scientific Paper Award 2009” for Ruthenium 106 Plaque Brachytherapy : Indications and Outcome in Ocular Tumors by AROICON
  • Member of American Society of Clinical Oncology (ASCO)
  • Member of American Society for Radiation Oncology (ASTRO)
  • Member of European Society of Medical Oncology (ESMO)
  • Member of “International Union Against Cancer”, UICC, Geneva
  • Member of Association of Radiation Oncologists of India (AROI)
  • President of Association of Radiation Oncologists of India (AROI, AP Chapter)
  • Member of Indian College of Radiation Oncology (ICRO)
  • General Secretary, Indian College of Radiation Oncology (ICRO)
  • Member of Indian Society of Oncology (ISO)
  • Member of Civil Assistant Surgeon’s Association, Andhra Pradesh
  • Member of Indian Medical Association (IMA)
  • Member of Indian Co-operative Oncology Network (ICON)
  • Member of Indian Brachytherapy Society, Chennai
  • “Ruthenium 106 Plaque Brachytherapy : Indications and Outcome in Ocular Tumors” at 4th World Congress of International Federation of Head & Neck Oncologic Societies (IFHNOS) – 2010 at Seoul, Korea from June 15-19, 2010.
  • “Retinoblastoma : Diagnosis and Management” at ICRO – 2010, CME, Vellore from May 8-9, 2010.
  • “Brain Tumors” at Advances in Oncology – 2010 based on 2nd Edition of ASCO-SEP 2010, Chennai on May 8, 2010.
  • “Role of Chemotherapy in Malignant Gliomas” at 2nd Annual Conference of the Indian Society of Neuro-oncology ISNOCON – 2010, Chennai on April 2-4, 2010.
  • “Management of Oral Cancers – Role of Chemotherapy and Radiation therapy” at Kamineni Inst. of Dental Sciences, Narketpally on March 24, 2010.
  • “Yes, You can prevent Cancer in Women” at GE-Energy, Hyderabad Technology Center, Hitec City, Hyderabad on March 8, 2010.
  • “Management of Advanced Lung Cancer” at Ask’10 - International Conference on Trends & Treatments in Head, Neck & Thoracic Cancer at Gurgaon, New Delhi on March 6-7, 2010.
  • “Prevent, Detect & Arrest Cancer!” at 8th Biennial International Conference & Exhibition on Petroleum Geophysics at HICC, Hyderabad from February 1-3, 2010.
  • “Paradigm Shift in the Treatment and Outcome of Retinoblastoma – A Large Series with Protocol Based Management” at 47th National Conference of Indian Academy of Pediatrics (IAP) at HICC, Hyderabad from January 7-10, 2010.
  • “Histopathology of Retinoblastoma after primary Chemotherapy” at AROICON – 2009, Hyderabad from November 26th – 29th, 2009.
  • Ruthenium 106 Plaque Brachytherapy : Indications and Outcome in Ocular Tumors – Shifting Paradigms in Head and Neck Oncology (IFHNOS) 2010; Vol. 1; pp: 233.
  • Histopathology of Retinoblastoma after primary Chemotherapy(Abs) - Saudi Journal of Ophthalmology 2010; Vol. 24; pp: 100.
  • A typical presentation of Ciliary body Medulloepithelioma (Abs) - Saudi Journal of Ophthalmology 2010; Vol.24; pp: 116.
  • Ruthenium 106 Plaque Brachytherapy: Indications and Outcomes in Ocular Tumors (Abs) - Saudi Journal of Ophthalmology 2010; Vol. 24; pp: 121.
  • Largest series of orbital Schwannoma: Clinical manifestations and outcomes (Abs) - Saudi Journal of Ophthalmology 2010; Vol. 24; pp: 131.
  • Genotype-Phenotype and Clinical correlation in Retinoblastoma (Abs) - Saudi Journal of Ophthalmology 2010; Vol. 24; pp: 129.
  • Cervical Cancer Screening : Role of Serotyping of HPV as bridge of Cytopathology and molecular typing? – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S75.
  • Genotype and phenotype correlation analysis in Retinoblastoma – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S75.
  • Ruthenium 106 Plaque Brachytherapy : Indications and outcome in Ocular Tumors – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2):S88.
  • Role of HPV, Cell cycle markers and epigenetic modifications at DNMT3L region in Ocular surface Squamous Neoplasia – Journal of Cancer Research and Therapeutics 2009; Vol. 5(2) :S97.
Pending draft ... Click to resume editing
Discard draft